1
|
Adeyemi D, Arokoyo D, Hamed M, Dare A, Oyedokun P, Akhigbe R. Cardiometabolic Disorder and Erectile Dysfunction. Cell Biochem Biophys 2024:10.1007/s12013-024-01361-2. [PMID: 38907942 DOI: 10.1007/s12013-024-01361-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2024] [Accepted: 06/12/2024] [Indexed: 06/24/2024]
Abstract
Erectile dysfunction (ED), which is defined as the inability to attain and maintain a satisfactory penile erection to sufficiently permit sexual intercourse, is a consequence and also a cause of cardiometabolic disorders like diabetes mellitus, systemic hypertension, central obesity, and dyslipidemia. Although there are mounting and convincing pieces of evidence in the literature linking ED and cardiometabolic disorders, impairment of nitric oxide-dependent vasodilatation seems to be the primary signaling pathway. Studies have also implicated the suppression of circulating testosterone, increased endothelin-1, and hyperactivation of Ang II/ATIr in the pathogenesis of ED and cardiometabolic disorders. This study provides comprehensive details of the association between cardiometabolic disorders and ED and highlights the mechanisms involved. This would open areas to be explored as therapeutic targets in the management of ED and cardiometabolic disorders. It also provides sufficient evidence establishing the need for the management of cardiometabolic disorders as an adjunct therapy in the management of ED.
Collapse
Affiliation(s)
- Damilare Adeyemi
- Department of Physiology, Faculty of Basic Medical Sciences, College of Health Sciences, Osun State University, Osogbo, Osun State, Nigeria
| | - Dennis Arokoyo
- Department of Physiology, Federal University of Technology, Akure, Ondo State, Nigeria
| | - Moses Hamed
- Department of Medical Laboratory Sciences, Afe Babalola University, Ado Ekiti, Ekiti State, Nigeria
- The Brainwill Laboratories, Osogbo, Osun State, Nigeria
- Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria
| | - Ayobami Dare
- School of Medicine, University of Missouri, Columbia, MO, 65201, USA
| | - Precious Oyedokun
- Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria
- Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria
| | - Roland Akhigbe
- Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria.
- Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.
| |
Collapse
|
2
|
de Oliveira AA, Nunes KP. Hypertension and Erectile Dysfunction: Breaking Down the Challenges. Am J Hypertens 2021; 34:134-142. [PMID: 32866225 DOI: 10.1093/ajh/hpaa143] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2020] [Revised: 07/15/2020] [Accepted: 08/29/2020] [Indexed: 02/07/2023] Open
Abstract
A diagnostic of hypertension increases the risk of erectile dysfunction (ED); likewise, ED can be an early sign of hypertension. In both cases, there is evidence that endothelial dysfunction is a common link between the 2 conditions. During hypertension, the sustained and widespread release of procontractile factors (e.g., angiotensin II, endothelin 1, and aldosterone) impairs the balance between vasoconstrictors and vasodilators and, in turn, detrimentally impacts vascular and erectile structures. This prohypertensive state associates with an enhancement in the generation of reactive oxygen species, which is not compensated by internal antioxidant mechanisms. Recently, the innate immune system, mainly via Toll-like receptor 4, has also been shown to actively contribute to the pathophysiology of hypertension and ED not only by inducing oxidative stress but also by sustaining a low-grade inflammatory state. Furthermore, some drugs used to treat hypertension can cause ED and, consequently, reduce compliance with the prescribed pharmacotherapy. To break down these challenges, in this review, we focus on discussing the well-established as well as the emerging mechanisms linking hypertension and ED with an emphasis on the signaling network of the vasculature and corpora cavernosa, the vascular-like structure of the penis.
Collapse
Affiliation(s)
- Amanda Almeida de Oliveira
- Laboratory of Vascular Physiology, Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, Florida, USA
| | - Kenia Pedrosa Nunes
- Laboratory of Vascular Physiology, Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, Florida, USA
| |
Collapse
|
3
|
Zhang Q, Pan Y, Ma X, Yang H, Chang J, Hong L, Yan H, Zhang SH. Elevated Secretion of Aldosterone Increases TG/HDL-C Ratio and Potentiates The Ox-LDL-Induced Dysfunction of HUVEC. CELL JOURNAL 2021; 23:61-69. [PMID: 33650821 PMCID: PMC7944123 DOI: 10.22074/cellj.2021.7033] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/30/2019] [Accepted: 09/28/2019] [Indexed: 12/19/2022]
Abstract
Objective Atherosclerosis (AS) is one of the most common causes of human death and disability. This study is
designed to investigate the roles of aldosterone (Aldo) and oxidized low-density lipoprotein (Ox-LDL) in this disease by
clinical data and cell model.
Materials and Methods In this experimental study, clinical data were collected to investigate the Aldo role for the
patients with primary aldosteronism or adrenal tumors. Cell viability assay, fluorescence-activated cell sorting (FACS)
assay, apoptosis assay, cell aging analysis, and matrigel tube formation assay were performed to detect effects on
human umbilical vein endothelial cells (HUVECs) treated with Aldo and/or Ox-LDL. Quantitative polymerase chain
reaction (qPCR) and Western blot analysis were performed to figure out critical genes in the process of endothelial cells
dysfunction induced by Aldo and/or Ox-LDL.
Results We found that the Aldo level had a positive correlation with the TG/HDL-C ratio. Endothelial cell growth,
angiogenesis, senescence, and apoptosis were significantly affected, and eNOS/Sirt1, the value of Bcl-2/Bax and
Angiopoietin1/2 were significantly affected when cells were co-treated by Aldo and Ox-LDL.
Conclusion Elevated Aldo with high Ox-LDL together may accelerate the dysfunction of HUVEC, and the Ox-LDL,
especially for those patients with high Aldo should be well controlled. The assessment of the role of Aldo may provide
a theoretical basis for the effective prevention and investigation of a new treatment of AS.
Collapse
Affiliation(s)
- Qian Zhang
- Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First MedicaDepartment of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, Chinal University, Jinan, Shandong, China
| | - Yiwen Pan
- Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan, China.
| | - Xiaochun Ma
- Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First MedicaDepartment of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, Chinal University, Jinan, Shandong, China
| | - Hao Yang
- Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan, China
| | - Jun Chang
- Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan, China
| | - Ling Hong
- Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan, China
| | - Huiwen Yan
- Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan, China.
| | - S Hubing Zhang
- Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan, China. .,Hunan Key Laboratory of Animal models for Human Diseases, Central South University, Changsha, Hunan, China.,Breast Cancer Research Center, School of Life Sciences, Central South University, Changsha, Hunan, China
| |
Collapse
|
4
|
Pantelidis P, Sideris M, Viigimaa M, Avranas K, Deligkaris P, Zografou I, Lovic D. The Mechanisms of Actions of Aldosterone and its Antagonists in Cardiovascular Disease. Curr Pharm Des 2019; 24:5491-5499. [DOI: 10.2174/1381612825666190215100502] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2019] [Accepted: 02/10/2019] [Indexed: 11/22/2022]
Abstract
Background:
Aldosterone, through its actions on Mineralcorticosteroid Receptors (MR), controls fluid
and electrolyte balance, but also exerts various direct deleterious actions on the vasculature. A number of aldosterone
antagonists have been manufactured to reverse these effects.
Objective:
A comprehensive review of the underlying mechanisms of the actions of aldosterone and its antagonists
in cardiovascular disease.
Method:
The relevant studies indexed in PubMed, Scopus and Google Scholar databases, published from 2003 to
May 2018 were identified and reported.
Results:
Aldosterone binds to MR, activating them as intracellular transcription factors. Moreover, aldosterone,
through its actions on MR, as well as on another not fully explored class of receptors, triggers several signaling
pathways that produce rapid, non-genomic actions. In the vasculature, all these changes favor the establishment of
inflammation and cardiovascular dysfunction, which, in turn, lead to or exacerbate various cardiovascular diseases.
Mineralcorticosteroid Antagonists (MRA) are compounds that antagonize the action of aldosterone on MR.
Spironolactone was the first steroidal MRA to be commercially used. It showed beneficial clinical results, but
also a number of adverse effects. The next generation of steroidal MRA, exhibited lower potency but did not
induce many of these adverse reactions, due to their high selectivity for MR. The third generation of MRA compromises
the newly introduced non-steroidal MRA, which have a completely different chemical structure, they
induce different and more drastic changes to MR, they are much more specific and currently under clinical trials.
Conclusion:
New MRA, which block the aldosterone induced pathways in the vasculature, hold promising results
for the treatment of cardiovascular disease.
Collapse
Affiliation(s)
- Panteleimon Pantelidis
- 2nd Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Michail Sideris
- Women Health Research Unit, Queen Mary University of London, London, United Kingdom
| | - Margus Viigimaa
- Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia; Institute of Health Technologies, Tallinn University of Technology, Tallinn, Estonia
| | - Konstantinos Avranas
- 2nd Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Pavlos Deligkaris
- 2nd Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Ioanna Zografou
- 2nd Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Dragan Lovic
- Clinic for Internal Disease Intermedica, Cardiology department, Hypertension Center, Nis, Serbia
| |
Collapse
|